The next frontier in successful market access strategies will require intelligent approaches to collecting, analyzing and sharing value drivers of innovative therapies. Organizations must look beyond traditional methods of outcomes research to incorporate more robust data, more flexible approaches to data, and working collaboratively across stakeholders to scale.
In this session, leading organizations Novartis, Pfizer, and IBM Watson Health will discuss:
- The increasing importance of robust patient-level data and methods to collect it effectively;
- Using advanced analytics to visualize key data and generate new insights; and
- Building a scalable approach to assessing value quickly and efficiently.